Literature DB >> 12645673

School performance as a premorbid marker for schizophrenia: a twin study.

Clarine J van Oel1, Margriet M Sitskoorn, Marty P M Cremer, René S Kahn.   

Abstract

Evidence is accumulating that developmental abnormalities, poor neuromotor function, and increased problem behavior precede the manifestation of schizophrenia itself. Information on school performance and behavioral development was obtained for 49 pairs of twins in which at least one twin suffered from schizophrenia (20 monozygotic [MZ], 29 dizygotic [DZ]) and for 43 pairs of healthy control twins (25 MZ, 18 DZ). Cox regression was used to analyze the contribution of schizophrenia, zygosity, sex, and year of birth to the age at which developmental divergence occurred. In both MZ and DZ twin pairs with schizophrenia, divergence in school performance occurred about 7.5 years earlier than it did in control twins, at 12 years of age, preceding the onset of psychosis by 10 years. This suggests that the first prodromal signs of schizophrenia manifest themselves as cognitive symptoms at the onset of puberty. Underperformance at school might therefore be considered one of the first signs of an until then latent vulnerability for schizophrenia.

Entities:  

Mesh:

Year:  2002        PMID: 12645673     DOI: 10.1093/oxfordjournals.schbul.a006949

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  16 in total

1.  AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.

Authors:  Ruud van Winkel; Nico J M van Beveren; Claudia Simons
Journal:  Neuropsychopharmacology       Date:  2011-07-20       Impact factor: 7.853

2.  Poor school performance in offspring of patients with schizophrenia: what are the mechanisms?

Authors:  J Jundong; R Kuja-Halkola; C Hultman; N Långström; B M D'Onofrio; Paul Lichtenstein
Journal:  Psychol Med       Date:  2011-07-07       Impact factor: 7.723

3.  From antipsychotic to anti-schizophrenia drugs: role of animal models.

Authors:  Mark A Geyer; Berend Olivier; Marian Joëls; René S Kahn
Journal:  Trends Pharmacol Sci       Date:  2012-07-16       Impact factor: 14.819

4.  Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia.

Authors:  Gregory P Strauss; Daniel N Allen; Pinar Miski; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Res       Date:  2011-11-29       Impact factor: 4.939

5.  High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.

Authors:  A Vreeker; M P M Boks; L Abramovic; S Verkooijen; A H van Bergen; M H J Hillegers; A T Spijker; E Hoencamp; E J Regeer; R F Riemersma-Van der Lek; A W M M Stevens; P F J Schulte; R Vonk; R Hoekstra; N J M van Beveren; R W Kupka; R M Brouwer; C E Bearden; J H MacCabe; R A Ophoff
Journal:  Psychol Med       Date:  2015-12-01       Impact factor: 7.723

6.  Altered resting-state functional connectivity in young children at familial high risk for psychotic illness: A preliminary study.

Authors:  Sheeba Arnold Anteraper; Guusje Collin; Xavier Guell; Timothy Scheinert; Elena Molokotos; Maria Toft Henriksen; Raquelle Mesholam-Gately; Heidi W Thermenos; Larry J Seidman; Matcheri S Keshavan; John D E Gabrieli; Susan Whitfield-Gabrieli
Journal:  Schizophr Res       Date:  2019-12-02       Impact factor: 4.939

7.  Differences in developmental changes in academic and social premorbid adjustment between males and females with schizophrenia.

Authors:  Daniel N Allen; Gregory P Strauss; Kimberly A Barchard; Mary Vertinski; William T Carpenter; Robert W Buchanan
Journal:  Schizophr Res       Date:  2013-03-13       Impact factor: 4.939

Review 8.  Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Authors:  Rodrigo D Paz; Sonia Tardito; Marco Atzori; Kuei Y Tseng
Journal:  Eur Neuropsychopharmacol       Date:  2008-07-23       Impact factor: 4.600

9.  Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia.

Authors:  Dibyadeep Datta; Amy F T Arnsten
Journal:  ACS Chem Neurosci       Date:  2018-03-01       Impact factor: 4.418

10.  Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.

Authors:  Jacob A S Vorstman; Elemi J Breetvelt; Sasja N Duijff; Stephan Eliez; Maude Schneider; Maria Jalbrzikowski; Marco Armando; Stefano Vicari; Vandana Shashi; Stephen R Hooper; Eva W C Chow; Wai Lun Alan Fung; Nancy J Butcher; Donald A Young; Donna M McDonald-McGinn; Annick Vogels; Therese van Amelsvoort; Doron Gothelf; Ronnie Weinberger; Abraham Weizman; Petra W J Klaassen; Sanne Koops; Wendy R Kates; Kevin M Antshel; Tony J Simon; Opal Y Ousley; Ann Swillen; Raquel E Gur; Carrie E Bearden; René S Kahn; Anne S Bassett
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.